Annona muricata leaves have strongest cytotoxic activity against breast cancer cells

Main Article Content

Susi Endrini
Suherman Suherman
Wahyu Widowati

Abstract

BACKGROUND Plant-derived herbal compounds have a long history of clinical use, better patient tolerance and acceptance. They are freely available natural compounds that can be safely used to prevent various ailments. Plants have been the basis of traditional medicine throughout the world for thousands of years and are providing mankind with new remedies. The objective of this study was to determine the cytotoxicity of soursop (Anona muricata Linn) leaves and pearl grass (Hedyotis corymbosa (L.) Lam.) on the hormone-dependent human breast carcinoma Michigan Cancer Foundation-7 (MCF-7) cell line. METHODS This study used two types of solvents (water and ethanol) in the extraction process and two incubation times (24 hours and 48 hours) in the MTT assays to analyze the cytotoxic effects of both plants. RESULTS Preliminary results showed that the ethanolic extract of soursop leaves (SE) displayed cytotoxic effects against MCF-7 on 24- and 48-hour incubation times with IC50 values of 88.788 μg/ml and 14.678 μg/ml, respectively. Ethanolic pearl grass extract (PE) showed similar results, with IC50 values of 65.011 μg/ ml on 24-hour incubation time and 52.329 μg/ml on 48-hour incubation time against MCF-7 cell line. However, the water extract of both plants displayed lower cytotoxic effect against MCF-7 cell line. CONCLUSION The ethanolic extract of both plants displayed cytotoxic effect against MCF-7. Soursop (Anona muricata Linn) leaves have the strongest cytotoxic activity against MCF-7 breast cancer cell line.

Article Details

How to Cite
Endrini, S., Suherman, S., & Widowati, W. (2014). Annona muricata leaves have strongest cytotoxic activity against breast cancer cells. Universa Medicina, 33(3), 179–184. https://doi.org/10.18051/UnivMed.2014.v33.179-184
Section
Review Article

References

Ng CH, Phaty NB, Taib NA, Teh YC, Mun KS,

Amiruddin A, et al. Comparison of breast cancer

in Indonesia and Malaysia: a clinico-pathological

study between Dharmais Cancer Centre, Jakarta,

and University Malaya Medical Centre, Kuala

Lumpur. Asian Pacific J Cancer Prev 2011;12:

-6.

Paul J, Ganan R, Jayadeepa RM. Anticancer

activity of Graviola, an exciting medicinal plant

extract vs various cancer cell lines and a detailed

computational study on its potent anti-cancerous

leads. Curr Top Med Chem 2013;13:1666-73.

Cochrane CB, Nair PKR, Melnick SJ, Resek AP,

Ramachandran C. Anticancer effects of Annona

glabra plant extracts in human leukemia cell

lines. Anticancer Res 2008;28:965-72.

Patel TD, Jain V, Dodia R. Oldenlandia

corymbosa L: a phytopharmacological review.

Int J Phytophar 2014;4:79-82.

Endrini S. Antioxidant activity and

anticarcinogenic properties of “rumput mutiara”

{Hedyotis corymbosa (L.) Lam.} and

“pohpohan” {Pilea trinervia (Roxb.) Wight}. J

Medicinal Plant Res 2011;5:3715-8.

Courteau J. Annona muricata. Encyclopedia of

Life. Available at: http://www.eol.org/. Accessed

June 6, 2012.

Liaw CC, Chang FR, Chen Sl, Wu CC, Lee KH.

Novel cytotoxic monotetrahydrofuranic

annonaceus acetogenins from Annona montana.

Bioorg Med Chem 2005;13:4767-76.

Roesler R, Catharino RR. Malta LG. Antioxidant

activity of Annona crassiflora: characterization

of major components by electrospray ionization

mass spectrometry. Food Chem 2007;104:1048-

Ali AM, Macjen M, Hamid M, Lajis NH, El SS,

Murakoshi M. Antitumor promoting and

antitumor activities of the crude extract from

leaves of Juniperus chinensis. J Ethnopharmacol

;53:165-9.

Rachmani EPN, Suhesti TS, Widiastuti R,

Aditiyono A. The breast of anticancer from leaf

extract of Annona muricata against cell line in

T47D. Int J Appl Sci Technol 2012;2:157-64.

Fidianingsih I, Handayani ES. Annona muricata

aqueous extract suppresses T47D breast cancer

cell proliferation. Univ Med 2014;33:19-26.

Lee HZ, Bau D, Kuo CL, Tsai RY, Hen YC, Chan

YH. Clarification of the phenotypic

characteristics and anti-tumor activity of

Hedyotis diffusa. Am J Chin Med 2011;39:201-

Andriyani R, Risdian C, Udin Z. Cytotoxicity

assay from fractions of Hedyotis corymbosa

extract against breast cancer cell line T47D.

Indones J Cancer Chemoprev 2011;2:182-6.

Pandey K, Sharma PK, Dudhe R. Anticancer

activity of Parthenium hysterophorus and

Oldenlandia corymbosa Lam by SRB method.

Scientific Reports 2012;6:1-3.

Sasikumar JM, Maheshu V, Aseervatham GS,

Darsini DT. In vitro antioxidant activity of

Hedyotis corymbosa (L.) Lam. aerial parts.

Indian J Biochem Biophys 2010;47:49-52.

Chimkode R, Patil MB, Jalalpure S, Pasha TY,

Sarkar S. A study of hepatoprotective activity of

Hedyotis corymbosa Linn, in albino rats. Anc

Sci Life 2009;28:32-5.

Mammen D, Daniel M, Sane RT. Identification

of pharmacognostic and phytochemical

biomarkers to distinguish between Hedyotis

corymbosa (L) Lam and its adulterant, Glinus

oppositifolius (L) ADC. Res J Pharm Biol Chem

Sci 2011;2:649-56.

Hussain ZA. Kumaresan S. Phytochemical and

antimicrobial evaluation of Oldenlandia

corymbosa. Asian J Plant Sci Res 2013;3:155-

Noiarsa P, Ruhirawat S, Otsuka H,

Kanchanapoom T. Chemical constituents from

Oldenlandia corymbosa L of Thai origin. J Ant

Med 2008;62:249-50.

Agrawal S. Evaluation of antiulcer activity of

Oldenlandia corymbosa (L). Int J Res Dev

Pharm Sci 2013;2:363-7.

Sivapraksam SSK, Karunakaran K, Kuppusamy

S, Subashini TS. A review on phytochemical and

pharmacological profile of Hedyotis corymbosa

Linn. Int J Pharm Sci Rev Res 2014;26:320-4.